 |
 |
The MATRICS Consensus Cognitive
Battery (MCCB) is intended to provide a relatively
brief evaluation of key cognitive domains relevant
to schizophrenia and related disorders, and was designed
to address the following purposes:
 |
As an outcome measure
for clinical trials of cognition-enhancing
drugs for schizophrenia |
|
As an outcome measure for studies
of cognitive remediation |
|
As a measure of cognitive change
in repeated testing applications |
|
As a cognitive reference point for
non-intervention studies of schizophrenia
and related disorders |
|
|
|
|
 |
 |
|
The National Institute of
Mental Health (NIMH) Initiative, Measurement and Treatment
Research to Improve Cognition in Schizophrenia (MATRICS),
was designed to stimulate the development of psychopharmacological
agents to improve cognition in schizophrenia. The MATRICS
Consensus Cognitive Battery (MCCB) was one deliverable
from this Initiative. The selection of tests included
in the MCCB involved a broad-based interdisciplinary
consensus process that is described in more detail
on the MATRICS website (www.matrics.ucla.edu). The
committee members involved with this process are listed
on the MATRICS website as well. |
|
|
|
 |
|
